Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No interest at all.

<The clarifications would actually benefit both TPL as well as PTSC. If there is any clause preventing one party to do anything for the mutual benefit, that must be removed. It is a defective agreement, then.>

No one here is happy with the master agreement. However, I do not believe it is defective, in a legal sense. Are you challenging its legality w/o reading it?

In any case, you appear to be of the opinion that PTSC/TPL have knowledge about reexam status which they should make public, even though the PTO chooses not to do so. I hope you honestly do not believe that would be good for us.

GLTA, Opty

Share
New Message
Please login to post a reply